Browse By Region

Browse By Category
Recent News
By Category: Research
Soligenix reports positive results from Phase 1B trial of RiVax
(PBR) Soligenix has announced that the Phase 1B clinical trial demonstrated that the Aluminum hydroxide adjuvanted RiVax has induced immune responses in human volunteers. The adjuvanted RiVax was found to be safe and well tolerated in the study, conducted in healthy volunteers, and induced better ricin neutralising antibody levels in humans compared to adjuvant-free RiVax. Read More »
- August 31, 2012
- | Filed under North America, Countermeasures, Public Health, and Research
Scientists map first steps in flu antibody development
(ScienceDaily) National Institutes of Health scientists have identified how a kind of immature immune cell responds to a part of influenza virus and have traced the path those cells take to generate antibodies that can neutralize a wide range of influenza virus strains. Study researchers from the National Institute of Allergy and Infectious Diseases (NIAID), Read More »
- August 30, 2012
- | Filed under North America, Public Health, and Research
Global Warming Could Increase Likelihood of Pandemic Bird Flu, Researchers … – Medical Daily
Medical DailyGlobal Warming Could Increase Likelihood of Pandemic Bird Flu, Researchers …Medical DailyEarlier this summer, for example, Mexico killed 8 million chickens in order to stem the spread of H5N1. In addition, though humans may not necessarily be infected with avian flu, the strand H3N8 had killed 162 seals over the course of three months Read More »
- August 29, 2012
- | Filed under Research
Flu is transmitted before symptoms appear, study suggests
(Imperial College London) Research at Imperial College London examining influenza transmission in ferrets suggests that the virus can be passed on before the appearance of symptoms.
- August 29, 2012
- | Filed under Research
In war with ‘superbugs,’ Cedars-Sinai researchers see new weapon: Immune-boosting vitamin
(EurekAlert) Cedars-Sinai researchers have found that a common vitamin may have the potential to provide a powerful weapon to fight certain “superbugs,” antibiotic-resistant staph infections that health experts see as a threat to public health. The research, published in the September 2012 edition of The Journal of Clinical Investigation, found that high doses of the Read More »
- August 28, 2012
- | Filed under North America, Public Health, and Research